RBFOX2 and neoplasm: Our results show that most of the genes are negatively correlated with these drugs (based on IC50 values) between high- and low-risk groups in each tumor except for RBFOX2 in some tumors, YTHDF1 in SKCM and LUAD, FTO in LUSC and TGCT, and FMR1 in OV and UCS (Supplementary Figure S11).